Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 866.43M P/E - EPS this Y -13.30% Ern Qtrly Grth -
Income -65.81M Forward P/E -36.73 EPS next Y 97.10% 50D Avg Chg 13.00%
Sales 159.11M PEG -0.54 EPS past 5Y - 200D Avg Chg 27.00%
Dividend N/A Price/Book 7.15 EPS next 5Y 30.00% 52W High Chg -21.00%
Recommedations 1.50 Quick Ratio 4.06 Shares Outstanding 233.98M 52W Low Chg 453.00%
Insider Own 1.70% ROA -13.83% Shares Float 228.34M Beta 0.82
Inst Own 60.69% ROE -47.64% Shares Shorted/Prior 27.59M/31.09M Price 4.04
Gross Margin 62.03% Profit Margin -41.36% Avg. Volume 5,148,887 Target Price 11.35
Oper. Margin -53.62% Earnings Date Aug 1 Volume 10,175,200 Change 5.21%
About Ardelyx, Inc.

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to reduce serum phosphorus in adults with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among patients with kidney and/or heart failure; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Ardelyx, Inc. News
07/25/24 Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?
07/18/24 Ardelyx sues CMS over revamped kidney disease drug payment bundle
07/18/24 Ardelyx, Groups File Lawsuit Over Dialysis Payment System Coverage
07/18/24 Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024
07/17/24 Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines
07/15/24 Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?
07/02/24 To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
06/28/24 Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines
06/24/24 3 Promising Penny Stocks for the Most Astute Investors
06/22/24 When Will Ardelyx, Inc. (NASDAQ:ARDX) Become Profitable?
06/16/24 3 Stocks Under $10 With the Potential to Make You a Millionaire
05/30/24 Ardelyx, Inc. Reports Employment Inducement Grants
05/30/24 Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
05/22/24 Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
05/21/24 Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
05/19/24 The 3 Best Penny Stocks to Buy in May 2024
05/16/24 Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
05/15/24 7 Cheap Penny Stocks to Buy Now: May 2024
05/07/24 Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
05/04/24 Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript
ARDX Chatroom

User Image Belanagorgio Posted - 4 hours ago

$ARDX does value come from insurance companies refusing to pay for effective treatments or from a fantastic drug that treats illness much more effectively? Who are we as a nation?

User Image FerreroRocher Posted - 11 hours ago

$ARDX Is it Monday yet?

User Image ToadTrader Posted - 12 hours ago

$ARDX Nice way to end the Day... The Week! Stay GREEN.... Trade Safe.... and have a great weekend! I'm sure it will be an interesting week.... End of Month.... Beginning of Next Month... and Earnings Report...LOL

User Image findingthestock Posted - 12 hours ago

$ARDX Ardelyx employees are posting about HR 5074 knowing the importance of getting it passed and for the company to benefit

User Image Shorthand Posted - 13 hours ago

$ARDX estimating -11%. Last time they said that we beat it by 128%

User Image jamstah Posted - 14 hours ago

@valueforme never had any luck with biotechs in Ophthalmology. If you want a better bet for earnings next week it would be $ARDX. Plenty of script data out in the wild showing demand for both their drugs. Market over reaction to not applying for Medicare coverage for hyperphosphotemia. Their IBS indication alone is worth $5-7. Entered and exited multiple times, 5x returns and nearly always runs after earnings

User Image PIFFED Posted - 14 hours ago

$ARDX Time for Raab to drop the A Bomb on the shorts.

User Image EV_Investor Posted - 15 hours ago

$ARDX person on Twitter that previously shared script data has calculations of $255-$260M runrate. Take that as you will.

User Image Machiaveltrade Posted - 15 hours ago

$ARDX cumulate for next week

User Image BioRich Posted - 15 hours ago

$BBIO $TRVI $GERN $ARDX and $ARVN looking good today and we expect them to hold into next week. $TRVI is a sleeper here so keep an eye on them. Like and follow for more tips/suggestions. We'd love to hear yours too. Let's make some money. Cheers!

User Image Rookie1979xxx Posted - 16 hours ago

$ARDX just sold all my shares,i wanted to hold until earnings but i do not think it will rise this year anymore,to many issues here,wish all the bulls(exept the ines who blocked me)all the best,good luck you will need it with the gamble✌️

User Image WsuDocta Posted - 16 hours ago

$ARDX Does anyone know if "H.R. 6790 - New Era of Preventing End-Stage Kidney Disease Act" effects us?

User Image Weisbart Posted - 16 hours ago

$ARDX @ My God, this share is so tightly controlled by the market makers. It's unbelievable. The price rises to over 4 percent, then it is sent down by over 5 percent so that 100,000 additional shares can be bought. You could see this almost every day and at the end of the day, when the share was pushed back below zero, another 500,000 shares were bought.

User Image newandimproveddonkeykong Posted - 16 hours ago

$ARDX Tuts are still buying...this was a little under 72% last month

User Image Sharebuy Posted - 16 hours ago

$ARDX it is almost the as two years ago, when the share price dropped from 1.6 to .6ct. For a lot of people this was a risk, but I bought huge. I took some profit, and my average is stil low. So I am buying, because I know this will go above 20$ soon in few years. So the price is cheap. I am buying and accumulate more shares. If the price dropped more, i will buy more. ARDX is a gold mine.

User Image ISEEITALLTHETIME Posted - 16 hours ago

$ARDX How many fell for the pump this time? They have only been doing it the last 4 days. Glad I sold this turd three days ago. No way I was holding this going into earnings. Because earnings will be meaningless, unless the bundling issue is fixed and I have a feeling Isbrella sales aren't that hot. That's why they filed the lawsuit, out of desperation.

User Image ToadTrader Posted - 16 hours ago

$ARDX It is Time.... https://littleblacksubs.wordpress.com/wp-content/uploads/2015/10/tumblr_mk4p0fiagg1qllztgo1_250.gif

User Image Microscope Posted - 16 hours ago

$ARDX Results will be great on August 1st,followed by the long awaited Chinese approval.Upswing thereafter.

User Image Coach_B1067 Posted - 16 hours ago

$ARDX I love it when I am right...lol.

User Image Bluefin1976 Posted - 16 hours ago

$ARDX $4’s are coming

User Image J3DI Posted - 17 hours ago

$ARDX bring it to Delisting....easyst Short... absolutely criminal FRAUDs

User Image Coach_B1067 Posted - 17 hours ago

$ARDX Blue and J3di should be posting soon.

User Image BroccoliRaab Posted - 17 hours ago

$ARDX green to red

User Image Rookie1979xxx Posted - 17 hours ago

$ARDX this stock used to run 20 percent pre earnings

User Image BroccoliRaab Posted - 17 hours ago

$ARDX dexcom down 40%. No more kidney

User Image ToadTrader Posted - 17 hours ago

$ARDX To the Shorts.... You been speared.... Catch you on the next round!

User Image 4Reel Posted - 17 hours ago

$ARDX great push today like to see it break the last high of 6.27 by earnings to give a higher high. Gap starts at 6.47 🚀 bios liked what they heard today from PCE looks like

User Image JustB4SnR1se Posted - 17 hours ago

$ARDX long way to recover. hope today will make a nice setup for next week.

User Image PIFFED Posted - 17 hours ago

$ARDX BIG opening candle. Let’s have a great day today, get the shorts scrambling, Raab could put a mic drop on them with any news

User Image M_OF_E Posted - 18 hours ago

$ARDX Interesting article https://finance.yahoo.com/news/ardelyx-ardx-expected-beat-earnings-140153169.html

Analyst Ratings
HC Wainwright & Co. Buy Jul 18, 24
Wedbush Outperform Jul 18, 24
Citigroup Buy Jul 3, 24
Cantor Fitzgerald Overweight Jun 20, 24
Piper Sandler Overweight May 24, 24
Wedbush Outperform May 24, 24
Citigroup Buy May 3, 24
Wedbush Outperform May 3, 24
Wedbush Outperform Apr 17, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rosenbaum David P. Chief Development Of.. Chief Development Officer Jan 08 Sell 6.64 30,000 199,200 286,596 01/10/24
Renz Justin A Chief Financial Offi.. Chief Financial Officer Dec 26 Sell 6.36 225,000 1,431,000 182,426 12/28/23
Renz Justin A Chief Financial Offi.. Chief Financial Officer Dec 26 Option 0.99 75,000 74,250 407,426 12/28/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Dec 18 Sell 6.07 5,675 34,447 316,596 12/20/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Dec 14 Sell 5.55 7,000 38,850 322,271 12/15/23
GRAMMER ELIZABETH A See Remarks See Remarks Dec 11 Sell 5.0785 50,000 253,925 275,675 12/13/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Dec 08 Sell 5.2738 20,000 105,476 329,271 12/08/23
Williams Laura A Chief Medical Office.. Chief Medical Officer Nov 20 Sell 4.3622 2,581 11,259 266,191 11/22/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Nov 20 Sell 4.36 3,767 16,424 113,293 11/22/23
Rodriguez Susan Chief Commercial Off.. Chief Commercial Officer Nov 20 Sell 4.3622 4,714 20,563 346,973 11/22/23
Renz Justin A Chief Financial Offi.. Chief Financial Officer Nov 20 Sell 4.3622 2,873 12,533 332,426 11/22/23
RAAB MICHAEL President & CEO President & CEO Nov 20 Sell 4.3622 11,368 49,589 867,868 11/22/23
GRAMMER ELIZABETH A See Remarks See Remarks Nov 20 Sell 4.3622 2,384 10,399 325,675 11/22/23
Felsch Robert Ora See Remarks See Remarks Nov 20 Sell 4.3622 1,044 4,554 117,066 11/22/23
Blanks Robert See Remarks See Remarks Nov 20 Sell 4.3622 2,835 12,367 260,453 11/22/23
Williams Laura A Chief Medical Office.. Chief Medical Officer Nov 15 Sell 3.9999 25,000 99,998 266,839 11/17/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Oct 10 Sell 4 1,644 6,576 365,378 10/12/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Sep 08 Sell 4.55 2,897 13,181 367,022 09/12/23
Williams Laura A Chief Medical Office.. Chief Medical Officer Jun 27 Sell 3.3453 25,000 83,632 294,430 06/29/23
Blanks Robert See Remarks See Remarks Jun 23 Sell 3.63 33,333 120,999 266,134 06/27/23
Blanks Robert See Remarks See Remarks Jun 23 Option 3.42 33,333 113,999 299,467 06/27/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Mar 29 Sell 4.6293 3,000 13,888 113,096 03/31/23
Felsch Robert Ora See Remarks See Remarks Aug 31 Buy .6188 3,000 1,856 91,418 09/01/22
Rosenbaum David P. Chief Development Of.. Chief Development Officer Aug 31 Buy 0.62 3,000 1,860 92,369 09/01/22
Rosenbaum David P. Chief Development Of.. Chief Development Officer Aug 31 Sell 0.92 3,000 2,760 89,369 09/01/22
Renz Justin A Chief Financial Offi.. Chief Financial Officer Aug 31 Buy 0.6188 3,000 1,856 263,549 09/01/22
Williams Laura A Chief Medical Office.. Chief Medical Officer Aug 31 Buy 0.6188 3,000 1,856 245,441 09/01/22
RAAB MICHAEL President & CEO President & CEO Aug 31 Buy 0.6188 3,000 1,856 665,680 09/01/22
GRAMMER ELIZABETH A See Remarks See Remarks Aug 31 Buy 0.6188 3,000 1,856 256,110 09/01/22
Rodriguez Susan Chief Commercial Off.. Chief Commercial Officer Aug 22 Sell 0.98 3,420 3,352 286,173 08/24/22
Rosenbaum David P. Chief Development Of.. Chief Development Officer Aug 22 Sell 0.98 1,955 1,916 89,369 08/24/22
Blanks Robert See Remarks See Remarks Aug 22 Sell 0.98 1,458 1,429 317,669 08/24/22
RAAB MICHAEL President & CEO President & CEO Aug 22 Sell 0.98 6,146 6,023 662,680 08/24/22
GRAMMER ELIZABETH A See Remarks See Remarks Aug 22 Sell 0.98 1,236 1,211 253,110 08/24/22
Williams Laura A Chief Medical Office.. Chief Medical Officer Aug 22 Sell 0.98 1,276 1,250 242,441 08/24/22
Renz Justin A Chief Financial Offi.. Chief Financial Officer Aug 22 Sell 0.98 1,498 1,468 260,549 08/24/22
Renz Justin A Chief Financial Offi.. Chief Financial Officer Jun 06 Sell 0.64 73,312 46,920 262,047 06/08/22
Rodriguez Susan Chief Commercial Off.. Chief Commercial Officer Jun 06 Sell 0.64 43,920 28,109 289,593 06/08/22
Blanks Robert See Remarks See Remarks Jun 06 Sell 0.64 73,312 46,920 324,315 06/08/22
GRAMMER ELIZABETH A See Remarks See Remarks Jun 06 Sell 0.64 60,821 38,925 254,346 06/08/22
Rosenbaum David P. Chief Development Of.. Chief Development Officer Jun 06 Sell 0.64 61,640 39,450 89,866 06/08/22
RAAB MICHAEL President & CEO President & CEO Jun 06 Sell 0.64 103,624 66,319 668,826 06/08/22
Blanks Robert See Remarks See Remarks Feb 22 Sell 0.67 1,752 1,174 399,116 02/25/22
SANDELL SCOTT D 10% Owner 10% Owner Dec 09 Sell 1.32 2,881,570 3,803,672 2,258,850 12/27/21
BASKETT FOREST 10% Owner 10% Owner Dec 09 Sell 1.32 2,881,570 3,803,672 2,258,850 12/27/21
GRAMMER ELIZABETH A See Remarks See Remarks Dec 15 Option 2.32 42,000 97,440 113,527 12/15/20
GRAMMER ELIZABETH A See Remarks See Remarks Dec 15 Sell 7.3 42,000 306,600 72,527 12/15/20